Fast food consumption may raise risk of nonalcoholic fatty liver disease Dr. Kamal Kant Kohli12 Jan 2023 12:00 PM ISTCalifornia: Consumption of fast food is associated with NAFLD (nonalcoholic fatty liver disease), a potentially life-threatening condition...
Management of acute kidney injury in cirrhosis patients: Expert review on AGA's evaluation Medha Baranwal5 Jan 2023 11:30 PM ISTUSA: A recent article reports an expert review of the AGA (American Gastroenterological Association) clinical practice update on evaluating and...
Rifaximin and lactulose combo effectively, decreases mortality in hepatic encephalopathy Aditi15 Dec 2022 10:00 AM ISTChina: Metabolic disorders induce hepatic encephalopathy (HE), which causes severe liver disease and mismanaged central nervous system. Improving HE...
First-degree relatives of patients with NAFLD at risk of developing liver disease Dr. Kamal Kant Kohli3 Nov 2022 8:30 PM ISTNonalcoholic fatty liver disease (NAFLD) afflicts approximately one-fourth of the general population worldwide and it has emerged as an important...
Presence of parietal edema increases risk of ascitic fluid leak after paracentesis in liver cirrhosis patients Medha Baranwal25 Oct 2022 8:00 PM ISTMumbai: A minority of patients with cirrhosis develop persistent leaks after paracentesis, research published in the Journal of Clinical and...
Long-term carvedilol therapy reduces decompensation risk among cirrhosis patients Dr. Shravani Dali19 Oct 2022 7:30 PM ISTCarvedilol significantly decreases the risk of decompensation in patients with cirrhosis and clinically significant portal hypertension (CSPH),...
Daily step count may predict hospital admission and mortality rates in cirrhosis patients Dr.Niharika Harsha B6 Sept 2022 8:00 PM ISTA new study found that Daily step count predicted hospital admission and mortality rates in cirrhosis patients. The study was published in the journal...
The AGPR Index - novel non-invasive marker in Chronic Hepatitis B Dr.Niharika Harsha B27 July 2022 8:00 PM ISTResearchers from China developed a novel, simple, accurate, and noninvasive marker to predict Liver Fibrosis and Cirrhosis in Chronic Hepatitis B...
Hepatitis-C treatment access in reducing morbidity and mortality among people who inject drugs Isra Zaman12 July 2022 10:00 AM ISTA longitudinal cohort study of persons with a history of injection drug use has found that more people who inject drugs (PWID) are receiving Hepatitis...
Statin use tied to lower risk of acute-on-chronic liver failure in cirrhosis patients: Study Medha Baranwal3 May 2022 11:00 AM ISTUSA: Statin use is significantly associated with reduced development of high-grade acute-on-chronic liver failure (ACLF) in patients with cirrhosis,...
PPIs use improves survival in cirrhosis patients with prior GI bleeding, study shows Medha Baranwal13 April 2022 10:45 PM ISTUSA: A recent study has found that the use of proton pump inhibitors (PPIs) for people with prior gastrointestinal bleeding (GIB) is associated with...
Kisspeptin: A new drug for treatment of NAFLD Dr. Kamal Kant Kohli9 April 2022 10:00 AM ISTGlobally, NAFLD is the most common form of chronic liver disease that affects children and adults and is linked to the rise in obesity and Type 2...
